Reuters logo
4 个月前
BRIEF-Acorda qtrly GAAP net loss $0.41 per diluted share
2017年4月27日 / 上午10点24分 / 4 个月前

BRIEF-Acorda qtrly GAAP net loss $0.41 per diluted share

April 27 (Reuters) - Acorda Therapeutics Inc:

* Acorda provides financial and pipeline update for first quarter 2017

* Acorda Therapeutics Inc- projected year-end cash balance greater than $200 million

* Acorda Therapeutics Inc- 2017 combined research and development and SG&A operating expense guidance revised to $330 - $350 million, a reduction of about $50 million

* Acorda Therapeutics Inc - qtrly GAAP net loss for quarter ended March 31, 2017, $0.41 per diluted share

* Acorda Therapeutics Inc - qtrly non-gaap net loss for quarter ended march 31, 2017 $.08 per diluted share

* Q1 earnings per share view $0.09, revenue view $127.3 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below